Abstract
Gene Therapy for Beta Thalassemia: Preliminary Results from the PHASE I/II Tiget-Bthal Trial of Autologous Hematopoietic Stem Cells Genetically Modified with GLOBE Lentiviral Vector
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have